Skip to main content
. 2021 Jan 11;13(10):1079–1093. doi: 10.1002/pmrj.12517

Table 3.

Proportion of Completers and Discontinuers who Responded to PRO Measures in the Lower Limb Population *

Tx1 Tx2 Tx3 Tx4 Tx5 Tx6 Tx7 Tx8 Total
DAS, N 529 465 394 336 257 184 128 39 2332
Completers, N (%) 320 (60.5) 316 (68.0) 298 (75.6) 272 (81.0) 224 (87.2) 171 (92.9) 122 (95.3) 37 (94.9) 1760 (75.5)
Discontinuers, N (%) 209 (39.5) 149 (32.0) 96 (24.4) 64 (19.0) 33 (12.8) 13 ( 7.1) 6 ( 4.7) 2 ( 5.1) 572 (24.5)
NPRS, N 140 155 169 161 146 101 76 25 1488
Completers, N (%) 87 (62.1) 109 (70.3) 127 (75.1) 129 (80.1) 130 (89.0) 94 (93.1) 73 (96.1) 25 (100.0) 1086 (73.0)
Discontinuers, N (%) 53 (37.9) 46 (29.7) 42 (24.9) 32 (19.9) 16 (11.0) 7 ( 6.9) 3 ( 3.9) 0 ( 0.0) 402 (27.0)
Patient Satisfaction, N 146 159 170 161 147 100 76 25 984
Completers, N (%) 89 (61.0) 111 (69.8) 127 (74.7) 129 (80.1) 131 (89.1) 93 (93.0) 73 (96.1) 25 (100.0) 778 (79.1)
Discontinuers, N (%) 57 (39.0) 48 (30.2) 43 (25.3) 32 (19.9) 16 (10.9) 7 ( 7.0) 3 ( 3.9) 0 ( 0.0) 206 (20.9)

DAS = Disability Assessment Scale; N = number of patients; NPRS = Numeric Pain Rating Scale; Tx = treatment session.

*

To be labeled a study “completer,” patients had to meet all of the following criteria: (1) did not discontinue within the 96‐week study period, (2) were not lost to follow‐up, and (3) completed the Final Assessment form. Any patient that did not meet all the criteria for a study completer, was labeled a study “discontinuer.”

The proportion of completers and discontinuers shown for DAS are representative of each subscale (dressing, hygiene, pain, posture, and mobility), as the sample size was the same for all subscales at each treatment session.

The proportion of completers and discontinuers shown for the patient satisfaction questionnaire includes those that responded with “not applicable”. At each treatment session, the sample size was not the same for all nine items in the satisfaction questionnaire. To be conservative, the data shown in the table represent the lowest response rate observed at each treatment session.